Table 4.
Result of the Prediction Model of Unmitigated Pain Using the Linear Regression Model
| Variable | Estimate | Std Err | T | p |
|---|---|---|---|---|
| Intercept | 7.646 | 1.228 | 6.228 | 0.000*** |
| HgbSC | −1.566 | 0.890 | −1.761 | 0.088 |
| SB+Thal or SOArab | −5.479 | 2.332 | −2.349 | 0.025* |
| Age at baseline−18 | 0.001 | 0.034 | 0.290 | 0.773 |
| Hydroxyurea user | −1.205 | 0.839 | −1.437 | 0.160 |
| Nonopioid user | −2.523 | 0.842 | −2.995 | 0.005** |
| SB+Thal or SOArab × (age at baseline −18) | 0.241 | 0.010 | 2.419 | 0.021* |
, **, and *** respectively denote levels .05, .01, and .001 of statistical significance.